Frequency and spectrum of founder and non-founder BRCA1 and BRCA2 mutations in a large series of Russian breast cancer and ovarian cancer patients.
Anna P SokolenkoTatiana N SokolovaValeria I NiElena V PreobrazhenskayaAglaya G IyevlevaSvetlana N AleksakhinaAlexandr A RomankoAlexandr A BessonovTatiana V GorodnovaElena I AnisimovaElena L SavonevichIlya V BizinIlya A StepanovPetr V KrivorotkoIgor V BerlevAlexey M BelyaevAlexandr V TogoEvgeny N ImyanitovPublished in: Breast cancer research and treatment (2020)
Full-length BRCA1 and BRCA2 sequencing is strongly advised to Slavic subjects, who have medical indications for BRCA1 and BRCA2 testing but are negative for recurrent BRCA1 and BRCA2 mutations.
Keyphrases